Features | Partner Sites | Information | LinkXpress
Sign In
PURITAN MEDICAL
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Vitamin-Boosted Stem Cells Reveal Potential to Cure Baldness

By BiotechDaily International staff writers
Posted on 06 Aug 2012
A team of Japanese researchers has discovered that VD3, an extremely active form of vitamin D, boosts stem cells to enhance and maintain their ability to trigger hair growth. This new study builds upon earlier research that has demonstrated how dermal papilla cells (DPCs) can stimulate epithelial stem cells to become hair.

“We had already discovered how VD3 increases the transforming growth factor TGF-ß2 and alkali-phosphatase activity--two essential features of hair-inducing DPCs. This time we focused on VD3’s therapeutic potency and values for hair regeneration,” said Kotaro Yoshimura, MD. “The results suggest that it may be useful in expanding human DPCs with good quality, and help establish a DPC transplantation therapy for growing hair.”

Dr. Yoshimura and Noriyuki Aoi, MD, from the University of Tokyo (UT) School of Medicine (Japan), led the study with investigators from Osaka University (Japan), and the Japan Science and Technology Agency (Saitama, Japan) in the study. After assessing how VD3 affected another crucial element for hair growth called Wnt10b gene expression, they gathered DPCs from volunteers who had undergone facelifts, incubated the DPCs with VD3 and then grafted them onto hairless skin samples gathered from rats.

“We found that treating the dermal papilla cells with VD3 significantly enhanced the growth of new hair over that of the control group,” Dr. Aoi said. “We also observed a better rate of maturation of the follicles. In other words, the hair grew thicker and lasted longer.”

“This study may contribute to the development of a cell-based therapy for hair regeneration,” said Anthony Atala, MD, editor of STEM CELLS Translational Medicine and director of the Wake Forest Institute for Regenerative Medicine (Winston-Salem, NC, USA). “The research team shows the potential impact of vitamin D to boost the capacity of certain cells in the skin to form hair.”

The study’s findings were reported July 2012 in the journal STEM CELLS Translational Medicine.

Related Links:

University of Tokyo School of Medicine
Osaka University
Japan Science and Technology Agency



Channels

Genomics/Proteomics

view channel
Image: Researchers have generated disease-free stem cells from patients with mitochondrial disease that can be converted into any cell type including neuronal progenitors (left) or heart cells (right). These could potentially be used for future transplantation into patients (Photo courtesy of Salk Institute of Biological Studies).

Methods Developed to Generate Normal Stem Cells from Patients with Mitochondrial Defects

A recent paper described two methods for converting cells from patients with mitochondrial defects into normal pluripotent stem cells that could be induced to differentiate into several different types of tissues.... Read more

Drug Discovery

view channel
Image: A new micelle delivery system for the protective polyphenols resveratrol and quercetin (mRQ) may have value in cancer chemotherapy (Photo courtesy of Oregon State University).

Micelles Containing Resveratrol and Quercetin Reverse Doxorubicin Cardiotoxicity

Cancer researchers blocked the toxic effects of the cancer drug doxorubicin (DOX) by administering it together with the plant antioxidants resveratrol and quercetin. Although in use for more than 40... Read more

Lab Technologies

view channel
Image: The Leica DM2500 LED Microscope for clinical laboratories and research applications (Photo courtesy of Leica Microsystems).

New LED Microscope Completes Line of Clinical and Research Tools

A popular microscope used for both clinical and research applications is now available with LED illumination. The Leica (Wetzlar, Germany) DM2500 and DM2500 LED microscopes represent a class of tools... Read more

Business

view channel

Teva Buys Allergan Generic Business Unit

Teva Pharmaceutical Industries (Petah Tikva, Israel) has bought the Allergan (Irvine, CA, USA) generic drugs business for USD 40.5 billion in cash and stock, solidifying its position as the world's largest generic drug maker. Under the terms of the agreement, Teva will pay USD 33.75 billion in cash and USD 6.... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.